熱門資訊> 正文
Oramed从Scilex获得1800万美元付款，批准每股股息0.25美元
2026-01-07 22:12
- Oramed Pharmaceuticals (ORMP) on Wednesday said that it has received an $18 million payment from Scilex Holdings, completing Scilex’s obligations under an option agreement.
- The company said the payment brings its total returns from the Scilex investment to $118 million, compared with an original investment of $99.5 million.
- Oramed said it retains a $27 million note and a $12 million convertible note from Scilex, as well as warrants and a nine-year royalty interest in Scilex products.
- Separately, Oramed’s board approved a cash dividend of $0.25 per share.
- The dividend will be paid on January 26, 2026, to shareholders on record as of January 16, 2026, and is expected to total about $10.5 million.
- ORMP +3.90% premarket to $3.19.
- Source: Press Release
More on Oramed Pharmaceuticals
- Oramed Pharmaceuticals: Scarred, Well-Capitalized, And Regrouping After Setback
- Seeking Alpha’s Quant Rating on Oramed Pharmaceuticals
- Historical earnings data for Oramed Pharmaceuticals
- Financial information for Oramed Pharmaceuticals
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
